Figure 1.
Time-to-progression (TTP) in 28 responders stratified by quality of response to extended therapy with single-agent rituximab. CR, complete remission; nPR, nodular partial remission; PR, partial remission.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.